Qynapse Shows Accuracy of QyScore, QyPredict in Alzheimer’s
Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer’s disease (AD), presented new data at the Alzheimer’s Association International Conference (AAIC) for QyScore® and QyPredict®. QyScore® is an FDA-cleared and CE-marked proprietary neuroimaging software platform that enables fully automated, high-resolution segmentation of brain structures…
